Tumor necrosis factor in the pathogenesis of infectious diseases
- PMID: 8403980
Tumor necrosis factor in the pathogenesis of infectious diseases
Abstract
Objectives: To review the immunologic role of the cytokines and the specific role that tumor necrosis factor (TNF) plays in response to infection. The influence of bacterial lipopolysaccharide on TNF, the cytokine cascade, and resultant pathologies are also reviewed.
Data sources: A MEDLINE search of the international English language literature from 1960 to the present was reviewed, but data from the past 5 yrs primarily formed the basis for this review.
Study selection: Those studies detailing the interaction of lipopolysaccharide, TNF, and other cytokines, and their roles in combating infection were emphasized. Investigations that described animal and human results served as the primary database.
Data extraction: Animal studies were selected based on the relevance of the model to the pathogenesis of the human clinical syndrome. Where they provided supportive evidence, patient studies were selected on the basis of study design.
Data synthesis: TNF plays a key role in the normal immune response to infection, limiting the spread of pathogens. Exaggerated physiologic responses occur under the influence of high concentrations of TNF that are released in response to overwhelming infection, resulting in aberrations in coagulation, cell adhesion, chemotaxis/transmigration, and vascular integrity. These pathologic effects may be inhibited by anti-TNF monoclonal antibodies and recombinant soluble receptor inhibitory proteins.
Conclusions: TNF exerts both physiologic and pathologic effects in response to infection; these events may lead to organ dysfunction and death. Anti-TNF therapies appear to attenuate the injurious effects of TNF.
Similar articles
-
Tumor necrosis factor: an updated review of its biology.Crit Care Med. 1993 Oct;21(10 Suppl):S415-22. Crit Care Med. 1993. PMID: 8403979 Review.
-
Biology of proinflammatory cytokines and their antagonists.Crit Care Med. 1994 Jul;22(7):S3-7. Crit Care Med. 1994. PMID: 8026189 Review.
-
Role of tumor necrosis factor-alpha in disease states and inflammation.Crit Care Med. 1993 Oct;21(10 Suppl):S447-63. doi: 10.1097/00003246-199310001-00006. Crit Care Med. 1993. PMID: 8403983 Review.
-
Preclinical review of anti-tumor necrosis factor monoclonal antibodies.Crit Care Med. 1993 Oct;21(10 Suppl):S441-6. doi: 10.1097/00003246-199310001-00005. Crit Care Med. 1993. PMID: 8403982 Review.
-
Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.Crit Care Med. 1993 May;21(5):780-9. Crit Care Med. 1993. PMID: 8482101 Review.
Cited by
-
Regulation of MCP-1 chemokine transcription by p53.Mol Cancer. 2010 Apr 20;9:82. doi: 10.1186/1476-4598-9-82. Mol Cancer. 2010. PMID: 20406462 Free PMC article.
-
Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.J Virol. 1997 Jun;71(6):4226-32. doi: 10.1128/JVI.71.6.4226-4232.1997. J Virol. 1997. PMID: 9151809 Free PMC article.
-
Tumor necrosis factor-α -308 G/A polymorphism and risk of sepsis, septic shock, and mortality: an updated meta-analysis.Oncotarget. 2017 Sep 13;8(55):94910-94919. doi: 10.18632/oncotarget.20862. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212277 Free PMC article.
-
Relation of a TNF gene polymorphism to severe sepsis in trauma patients.Ann Surg. 1999 Aug;230(2):207-14. doi: 10.1097/00000658-199908000-00011. Ann Surg. 1999. PMID: 10450735 Free PMC article.
-
Absence of Receptor Guanylyl Cyclase C Enhances Ileal Damage and Reduces Cytokine and Antimicrobial Peptide Production during Oral Salmonella enterica Serovar Typhimurium Infection.Infect Immun. 2018 Apr 23;86(5):e00799-17. doi: 10.1128/IAI.00799-17. Print 2018 May. Infect Immun. 2018. PMID: 29463616 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous